These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1770046)

  • 1. Clinical significance of urinary laminin P1 in diabetic patients.
    Nakajima C; Shimojo N; Naka K; Okuda K; Yamamoto M; Fujii S
    J Diabet Complications; 1991; 5(2-3):197-8. PubMed ID: 1770046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary laminin P1 as an index of glycemic control in children with insulin-dependent diabetes mellitus.
    Miyake H; Nagashima K; Yagi H; Onigata K
    Diabetes Res; 1993; 23(3):131-8. PubMed ID: 7536137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of laminin P1 in diabetics with advanced nephropathy.
    Pietschmann P; Schernthaner G; Schnack CH; Gaube S
    J Clin Pathol; 1988 Sep; 41(9):929-32. PubMed ID: 3192751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated N-acetyl-β-d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.
    Lee M; Hong N; Lee YH; Kang ES; Cha BS; Lee BW
    J Diabetes Complications; 2018 Aug; 32(8):777-783. PubMed ID: 29980431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of laminin fragments in the assessment of renal disease.
    Price RG; Taylor SA; Crutcher E
    Kidney Int Suppl; 1994 Nov; 47():S25-8. PubMed ID: 7869667
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A; Schleicher E
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of urinary enzymes in diabetic nephropathy.
    Morita E; Kaizu K; Uriu K; Hashimoto O; Komine N; Eto S
    J Diabet Complications; 1991; 5(2-3):158-9. PubMed ID: 1685160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Suzuki T; Igari Y; Oba K
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():586-91. PubMed ID: 12355814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
    Hirai M; Nakano H; Oba K; Metori S
    Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assay of laminin fragments in serum and urine as an indicator of renal damage induced by toxins.
    Price RG; Taylor SA; Crutcher E; Bergamaschi E; Franchini I; Mackie AD
    Toxicol Lett; 1995 May; 77(1-3):313-8. PubMed ID: 7618157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of microtransferrinuria in diabetic patients].
    Zhou Y; Zhang X; Wu J
    Zhonghua Nei Ke Za Zhi; 1997 Mar; 36(3):165-8. PubMed ID: 10374308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases.
    Setty S; Michael AA; Fish AJ; Michael Mauer S; Butkowski RJ; Virtanen I; Kim Y
    Mod Pathol; 2012 Jun; 25(6):859-68. PubMed ID: 22343787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of diabetic nephropathy.
    Hong CY; Chia KS
    J Diabetes Complications; 1998; 12(1):43-60. PubMed ID: 9442815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase].
    Nakamura S
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):522-33. PubMed ID: 1680783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
    Hayashi Y; Makino H; Ota Z
    Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
    J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.
    Lapsley M; Flynn FV; Sansom PA
    J Clin Pathol; 1993 May; 46(5):465-9. PubMed ID: 8320329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.